W. McLean Provan

The discovery and structural requirements of inhibitors of <i>p</i>-hydroxyphenylpyruvate dioxygenase

David L. Lee, Michael P. Prisbylla, Thomas H. Cromartie et al. · Weed Science · 1997 · 210 citations

Secondary Metabolite, Chemical Biology, Toxicological Mechanism +17

Species differences in response to trichloroethylene

M.S. Prout, W. McLean Provan, T. Green · Toxicology and Applied Pharmacology · 1985 · 144 citations

Environmental Chemistry, Pesticide Resistance, Species Differences +3

Inhibition of 4-Hydroxyphenylpyruvate Dioxygenase by 2-(2-Nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-Chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione

Martin K. Ellis, Alison C. Whitfield, Lesley A. Gowans et al. · Toxicology and Applied Pharmacology · 1995 · 113 citations

Bioorganic Chemistry, Aldehyde Dehydrogenase, Biochemistry +7

Pharmacokinetics and pharmacodynamics of NTBC (2‐(2‐nitro‐4‐fluoromethylbenzoyl)‐1,3‐cyclohexanedione) and mesotrione, inhibitors of 4‐hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers

Michael G. Hall, Martin F. Wilks, W. McLean Provan et al. · British Journal of Clinical Pharmacology · 2001 · 111 citations · Full text

Effect of intestinal microflora on the urinary metabolic profile of rats: a 1 H-nuclear magnetic resonance spectroscopy study

Rebecca E. Williams, H. W. Eyton-Jones, Mark J. Farnworth et al. · Xenobiotica · 2002 · 94 citations

Gastrointestinal Pharmacology, Digestive Tract, M-hppa Levels +22